These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 15455540)
1. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading. Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540 [TBL] [Abstract][Full Text] [Related]
2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868 [TBL] [Abstract][Full Text] [Related]
3. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081 [TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374 [TBL] [Abstract][Full Text] [Related]
5. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy. Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186 [TBL] [Abstract][Full Text] [Related]
7. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403 [TBL] [Abstract][Full Text] [Related]
9. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging. Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy. Liu ZL; Zhou Q; Zeng QS; Li CF; Zhang K J Int Med Res; 2012; 40(1):76-84. PubMed ID: 22429347 [TBL] [Abstract][Full Text] [Related]
11. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy. Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726 [TBL] [Abstract][Full Text] [Related]
12. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas]. Zhou GF; Wang XY; Gong CG; Liu F; Wang RW Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055 [TBL] [Abstract][Full Text] [Related]
13. Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2-18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging. Stadlbauer A; Prante O; Nimsky C; Salomonowitz E; Buchfelder M; Kuwert T; Linke R; Ganslandt O J Nucl Med; 2008 May; 49(5):721-9. PubMed ID: 18413402 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis. Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma. Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312 [TBL] [Abstract][Full Text] [Related]
17. Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas. Ankush A; Sardessai S Cureus; 2022 Nov; 14(11):e31841. PubMed ID: 36579207 [TBL] [Abstract][Full Text] [Related]
18. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135 [TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy of cerebral glioma after irradiation. Ng SH; Ko SF; Chen WC; Tang LM; Chang CN; Wai YY; Wan YL Chang Gung Med J; 2001 Nov; 24(11):708-16. PubMed ID: 11820651 [TBL] [Abstract][Full Text] [Related]
20. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]